C Fordy

1.1k total citations
15 papers, 879 citations indexed

About

C Fordy is a scholar working on Hepatology, Oncology and Surgery. According to data from OpenAlex, C Fordy has authored 15 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hepatology, 10 papers in Oncology and 7 papers in Surgery. Recurrent topics in C Fordy's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). C Fordy is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Colorectal Cancer Treatments and Studies (4 papers). C Fordy collaborates with scholars based in United Kingdom. C Fordy's co-authors include T G Allen-Mersh, S Earlam, Keith R. Abrams, C Glover, Dermot Burke, S. Jonas, Michael Davies, D C Henderson, Matthew L. Davies and T G Allen-Mersh and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Cancer.

In The Last Decade

C Fordy

15 papers receiving 860 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Fordy United Kingdom 13 575 440 267 185 79 15 879
S Earlam United Kingdom 9 460 0.8× 401 0.9× 243 0.9× 153 0.8× 47 0.6× 11 687
S. Tashiro Japan 11 278 0.5× 166 0.4× 288 1.1× 164 0.9× 24 0.3× 48 599
C. Lowdell United Kingdom 16 307 0.5× 93 0.2× 241 0.9× 166 0.9× 52 0.7× 29 660
William Ross Australia 16 219 0.4× 242 0.6× 221 0.8× 121 0.7× 20 0.3× 56 704
Kelsey C. Stoltzfus United States 12 360 0.6× 86 0.2× 136 0.5× 224 1.2× 49 0.6× 17 745
Joseph Kim United States 11 139 0.2× 283 0.6× 192 0.7× 87 0.5× 34 0.4× 26 563
Marianne Davies United States 14 482 0.8× 77 0.2× 75 0.3× 138 0.7× 44 0.6× 38 795
Olumide B. Gbolahan United States 18 312 0.5× 72 0.2× 116 0.4× 179 1.0× 59 0.7× 65 766
Chee Kian Tham Singapore 16 252 0.4× 71 0.2× 173 0.6× 146 0.8× 79 1.0× 40 653
Anne M. Horgan Ireland 16 741 1.3× 96 0.2× 900 3.4× 795 4.3× 95 1.2× 76 1.4k

Countries citing papers authored by C Fordy

Since Specialization
Citations

This map shows the geographic impact of C Fordy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Fordy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Fordy more than expected).

Fields of papers citing papers by C Fordy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Fordy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Fordy. The network helps show where C Fordy may publish in the future.

Co-authorship network of co-authors of C Fordy

This figure shows the co-authorship network connecting the top 25 collaborators of C Fordy. A scholar is included among the top collaborators of C Fordy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Fordy. C Fordy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Glover, C, et al.. (2000). Randomized trial of regional plus systemic fluorinated pyrimidine compared with systemic fluorinated pyrimidine in treatment of colorectal liver metastases. European Journal of Surgical Oncology. 26(5). 468–473. 28 indexed citations
2.
Fordy, C, C Glover, D C Henderson, et al.. (1999). Contribution of diet, tumour volume and patient-related factors to weight loss in patients with colorectal liver metastases. British journal of surgery. 86(5). 639–644. 19 indexed citations
3.
Fordy, C, et al.. (1998). Hepatic arterial floxuridine as second-line treatment for systemic fluorouracil-resistant colorectal liver metastases. British Journal of Cancer. 78(8). 1058–1060. 19 indexed citations
4.
Durand‐Zaleski, Isabelle, S Earlam, C Fordy, Michael Davies, & T G Allen-Mersh. (1998). Cost‐effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases. Cancer. 83(5). 882–888. 1 indexed citations
5.
Durand‐Zaleski, Isabelle, S Earlam, C Fordy, Michael Davies, & T G Allen-Mersh. (1998). Cost-effectiveness of systemic and regional chemotherapy for the treatment of patients with unresectable colorectal liver metastases. Cancer. 83(5). 882–888. 24 indexed citations
6.
Allen-Mersh, T G, et al.. (1998). Relation between depression and circulating immune products in patients with advanced colorectal cancer. Journal of the Royal Society of Medicine. 91(8). 408–413. 46 indexed citations
7.
Burke, Dermot, C Fordy, S Earlam, & T G Allen-Mersh. (1997). Hepatic arterial cannulation for regional chemotherapy is safe in patients with a liver metastasis volume of less than 1 litre. British Journal of Cancer. 75(8). 1213–1216. 9 indexed citations
8.
Earlam, S, C Glover, Michael Davies, C Fordy, & T G Allen-Mersh. (1997). Effect of regional and systemic fluorinated pyrimidine chemotherapy on quality of life in colorectal liver metastasis patients.. Journal of Clinical Oncology. 15(5). 2022–2029. 36 indexed citations
9.
Earlam, S, C Glover, C Fordy, Dermot Burke, & T G Allen-Mersh. (1996). Relation between tumor size, quality of life, and survival in patients with colorectal liver metastases.. Journal of Clinical Oncology. 14(1). 171–175. 137 indexed citations
11.
Burke, Dermot, et al.. (1995). Measurement of response to treatment in colorectal liver metastases. British Journal of Cancer. 71(4). 873–876. 24 indexed citations
12.
Fordy, C, et al.. (1995). Treatment interruptions and complications with two continuous hepatic artery floxuridine infusion systems in colorectal liver metastases. British Journal of Cancer. 72(4). 1023–1025. 13 indexed citations
13.
Burke, Dermot, S Earlam, C Fordy, & T G Allen-Mersh. (1995). Effect of aberrant hepatic arterial anatomy on tumour response to hepatic artery infusion of floxuridine for colorectal liver metastases. British journal of surgery. 82(8). 1098–1100. 23 indexed citations
14.
Dworkin, Michael, S Earlam, C Fordy, & T G Allen-Mersh. (1995). Importance of hepatic artery node involvement in patients with colorectal liver metastases.. Journal of Clinical Pathology. 48(3). 270–272. 14 indexed citations
15.
Allen-Mersh, T G, et al.. (1994). Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. The Lancet. 344(8932). 1255–1260. 404 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026